Brain Boost Program for Scleroderma
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being.The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.
Is the Brain Boost Program for Scleroderma safe for humans?
How is the Brain Boost Program treatment for scleroderma different from other treatments?
The Brain Boost Program for scleroderma is unique because it focuses on a comprehensive educational approach, involving a multi-professional team and patient interaction, rather than traditional drug treatments. This program is designed to empower patients through education and support, which is different from typical medical or exercise-based interventions.678910
What data supports the effectiveness of the Brain Boost Program treatment for scleroderma?
Who Is on the Research Team?
Yen Chen, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for individuals with systemic sclerosis, a condition that involves hardening of the skin and connective tissues. Participants should be interested in improving their cognitive function and well-being through an online educational program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week online educational group-based program tailored to people with systemic sclerosis
Follow-up
Participants are monitored for changes in cognitive function, pain, fatigue, mood, and self-management
What Are the Treatments Tested in This Trial?
Interventions
- Brain Boost Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Scleroderma Foundation
Collaborator